Nano-x Imaging Ltd (NNOX)
$8.92
Insights on Nano-x Imaging Ltd
Decreasing Revenue
Revenue is down for the last 4 quarters, 2.58M → 2.39M (in $), with an average decrease of 2.4% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -21.40M → -10.24M (in $), with an average increase of 54.4% per quarter
Vs BSX
In the last 3 years, Boston Scientific Corp. has given 73.3% return, outperforming this stock by 147.1%
Performance
- $8.81$9.03$8.92
1.18%
Downside
Day's Volatility :2.38%
Upside
1.22%
- $4.89$22.69$8.92
45.18%
Downside
52 Weeks Volatility :78.45%
Upside
60.69%
Returns
| Period | Nano-x Imaging Ltd | Sector (Health Care) | Index (Russel 2000) |
|---|---|---|---|
3 Months | 56.22% | 0.5% | 0.0% |
6 Months | 77.16% | 11.7% | 0.0% |
1 Year | 49.41% | 6.2% | 2.2% |
3 Years | -73.77% | 13.5% | -23.0% |
Highlights
Market Capitalization | 525.2M |
Book Value | $3.38 |
Earnings Per Share (EPS) | -1.08 |
Wall Street Target Price | 15.5 |
Profit Margin | 0.0% |
Operating Margin TTM | -400.04% |
Return On Assets TTM | -15.49% |
Return On Equity TTM | -29.49% |
Revenue TTM | 9.9M |
Revenue Per Share TTM | 0.18 |
Quarterly Revenue Growth YOY | 12.4% |
Gross Profit TTM | -6.9M |
EBITDA | -46.8M |
Diluted Eps TTM | -1.08 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.9 |
EPS Estimate Next Year | -0.46 |
EPS Estimate Current Quarter | -0.26 |
EPS Estimate Next Quarter | -0.25 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 73.77%
Technicals Summary
Sell
Neutral
Buy
Nano-x Imaging Ltd is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Nano-x Imaging Ltd | -2.51% | 77.16% | 49.41% | -73.77% | -58.89% |
 Stryker Corporation | -3.78% | 30.39% | 12.83% | 27.09% | 79.07% |
 Dexcom, Inc. | -1.37% | 70.19% | 10.47% | 31.82% | 344.58% |
 Boston Scientific Corp. | 7.83% | 47.17% | 43.37% | 73.31% | 95.99% |
 Abbott Laboratories | -4.16% | 13.71% | -1.74% | -12.82% | 36.02% |
 Medtronic Plc | -5.32% | 12.62% | -11.92% | -39.09% | -9.27% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Nano-x Imaging Ltd | NA | NA | NA | -0.9 | -0.29 | -0.15 | NA | 3.38 |
Stryker Corporation | 40.83 | 40.83 | 2.92 | 11.85 | 0.18 | 0.07 | 0.01 | 48.92 |
Dexcom, Inc. | 102.89 | 102.89 | 2.53 | 1.76 | 0.26 | 0.06 | NA | 5.37 |
Boston Scientific Corp. | 68.14 | 68.14 | 1.8 | 2.25 | 0.09 | 0.04 | NA | 13.16 |
Abbott Laboratories | 33.3 | 33.3 | 5.99 | 4.6 | 0.15 | 0.06 | 0.02 | 22.26 |
Medtronic Plc | 25.52 | 25.52 | 1.52 | 5.2 | 0.08 | 0.04 | 0.03 | 38.95 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Nano-x Imaging Ltd | Buy | $525.2M | -58.89% | NA | 0.0% |
Stryker Corporation | Buy | $128.2B | 79.07% | 40.83 | 15.44% |
Dexcom, Inc. | Buy | $54.6B | 344.58% | 102.89 | 14.95% |
Boston Scientific Corp. | Buy | $107.2B | 95.99% | 68.14 | 11.18% |
Abbott Laboratories | Buy | $185.5B | 36.02% | 33.3 | 13.96% |
Medtronic Plc | Buy | $106.7B | -9.27% | 25.52 | 13.0% |
Institutional Holdings
BlackRock Inc
6.41%State Street Corporation
2.30%Credit Suisse First Boston (CSFB)
1.21%Ibex Investors LLC
1.09%Morgan Stanley - Brokerage Accounts
1.05%Geode Capital Management, LLC
1.00%
Corporate Announcements
Nano-x Imaging Ltd Earnings
Nano-x Imaging Ltd’s price-to-earnings ratio stands at None
Read More
Company Information
nanox is developing the next generation of x-ray emitters based on groundbreaking nanotechnology. nanox emitters will finally bring x-ray imaging into the digital era, enabling novel 3d imaging systems with unmatched performance
Organization | Nano-x Imaging Ltd |
Employees | 164 |
CEO | Mr. Erez I. Meltzer |
Industry | Health Technology |
